Accredited InvestorsEmployee ShareholdersInstitutionsPrivate Companies Who We Serve Trading and Investing Data Solutions Private Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Browse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunities​Forge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All Insights Private Market Reports Market Insights Buying and Selling Pre-IPO​ All Reports​Private Market UpdatesForge Investment OutlookStartup News and Trends​Private Market Data and Analytics​Tech IPO Calendar for 2024​Private Market Explained​Buying Pre-IPO Shares​Selling Pre-IPO SharesGlossaryVideosFAQsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
Solutions
Insights
About
Who We Serve
Solutions
Trading and Investing
Institutional Trading
Individual Investing
Data Solutions
Private Asset Custody
Self-Directed IRA
Insights
Private Market Reports
Market Insights
Buying and Selling Pre-IPO​
About
Log In
Sign Up
Secondary Marketplace / Explore Private Companies / Passage Bio IPO

Passage Bio IPO

passagebio.comHealthcare / BioTech & Pharma

Passage Bio is a genetic medicines company focused on developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Buy or sell Passage Bio stock Learn more about Passage Bio stock
Register for Details

For more details on financing and valuation for Passage Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Passage Bio

Forge green plus iconForge green minus icon

What is Passage Bio's IPO price?

Passage Bio's IPO price is $0.9348 as of 1/18/24.
Forge green plus iconForge green minus icon

What is Passage Bio's IPO price?

The IPO price for Passage Bio will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Passage Bio pre-IPO?

Passage Bio is privately held company and is not publicly traded, therefor investing in Passage Bio pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my Passage Bio shares?

To determine the value of your Passage Bio shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Passage Bio shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell Passage Bio before it goes public?

Yes, you can seek to sell shares in Passage Bio while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is Passage Bio's funding to date?

Passage Bio has raised $225.5MM to date.
Forge green plus iconForge green minus icon

When was Passage Bio founded?

Passage Bio was founded in 2018.

Private companies exploring an IPO

Cerebras
Sector
Technology Hardware / Computing hardware
Last Round Est. Valuation
$2.87B
CoreWeave
Sector
Enterprise Software / Data Intelligence
Last Round Est. Valuation
$19B
Liquid Death
Sector
FoodTech / Food Products & Services
Last Round Est. Valuation
$1.4B
Vuori
Sector
Consumer & Lifestyle / Clothing, Fashion, Beauty & Apparel
Last Round Est. Valuation
$213.97MM
Cohesity
Sector
Enterprise Software / Data Management/​Storage
Last Round Est. Valuation
$3.4B
Klarna
Sector
FinTech / Lending
Last Round Est. Valuation
$5.41B
Chime
Sector
FinTech / Digital Banking
Last Round Est. Valuation
$24.93B
SKIMS
Sector
Consumer & Lifestyle / Clothing, Fashion, Beauty & Apparel
Last Round Est. Valuation
$4B
See the IPO Calendar
Trending Companies

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.